Jacob A Orville is EVP, GM, Screening of EXACT SCIENCES CORP. Currently has a direct ownership of 18,182 shares of EXAS, which is worth approximately $895,645. The most recent transaction as insider was on Feb 20, 2025, when has been sold 2,225 shares (Common Stock) at a price of $50.48 per share, resulting in proceeds of $112,318. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 18.2K
25.91% 3M change
87.85% 12M change
Total Value Held $895,645

JACOB A ORVILLE Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 20 2025
SELL
Payment of exercise price or tax liability
$112,318 $50.48 p/Share
2,225 Reduced 10.9%
18,182 Common Stock
Feb 20 2025
BUY
Grant, award, or other acquisition
-
4,805 Added 19.06%
20,407 Common Stock
Feb 19 2025
SELL
Payment of exercise price or tax liability
$53,898 $49.63 p/Share
1,086 Reduced 6.51%
15,602 Common Stock
Feb 19 2025
BUY
Exercise of conversion of derivative security
-
2,248 Added 11.87%
16,688 Common Stock
May 01 2024
SELL
Open market or private sale
$6,135 $60.15 p/Share
102 Reduced 0.7%
14,440 Common Stock
Apr 30 2024
BUY
Grant, award, or other acquisition
-
218 Added 1.48%
14,542 Common Stock
Mar 01 2024
SELL
Open market or private sale
$127,775 $59.32 p/Share
2,154 Reduced 13.07%
14,324 Common Stock
Feb 29 2024
BUY
Exercise of conversion of derivative security
-
4,724 Added 22.28%
16,478 Common Stock
Feb 27 2024
SELL
Open market or private sale
$106,896 $56.89 p/Share
1,879 Reduced 13.78%
11,754 Common Stock
Feb 26 2024
BUY
Exercise of conversion of derivative security
-
3,954 Added 22.48%
13,633 Common Stock
Feb 22 2024
SELL
Open market or private sale
$60,557 $59.78 p/Share
1,013 Reduced 9.47%
9,679 Common Stock
Feb 21 2024
SELL
Open market or private sale
$66,297 $61.5 p/Share
1,078 Reduced 11.07%
8,658 Common Stock
Feb 21 2024
BUY
Grant, award, or other acquisition
-
2,034 Added 15.98%
10,692 Common Stock
Feb 20 2024
BUY
Exercise of conversion of derivative security
-
2,248 Added 18.76%
9,736 Common Stock
Feb 15 2024
SELL
Open market or private sale
$59,341 $61.43 p/Share
966 Reduced 11.43%
7,488 Common Stock
Feb 14 2024
BUY
Exercise of conversion of derivative security
-
2,031 Added 19.37%
8,454 Common Stock
May 10 2023
SELL
Open market or private sale
$400,000 $80.0 p/Share
5,000 Reduced 43.77%
6,423 Common Stock
Mar 03 2023
SELL
Open market or private sale
$325,000 $65.0 p/Share
5,000 Reduced 30.45%
11,423 Common Stock
Feb 28 2023
SELL
Open market or private sale
$413,677 $60.55 p/Share
6,832 Reduced 29.38%
16,423 Common Stock
Feb 27 2023
BUY
Exercise of conversion of derivative security
-
3,954 Added 14.53%
23,255 Common Stock
Feb 22 2023
SELL
Open market or private sale
$169,971 $62.72 p/Share
2,710 Reduced 12.31%
19,301 Common Stock
Feb 21 2023
BUY
Exercise of conversion of derivative security
-
5,897 Added 21.13%
22,011 Common Stock
Feb 15 2023
SELL
Open market or private sale
$66,388 $69.59 p/Share
954 Reduced 5.59%
16,114 Common Stock
Feb 14 2023
BUY
Exercise of conversion of derivative security
-
2,030 Added 10.63%
17,068 Common Stock
Feb 24 2022
SELL
Open market or private sale
$330,662 $70.1 p/Share
4,717 Reduced 23.88%
15,037 Common Stock
JAO

Jacob A Orville

EVP, GM, Screening
Madison, WI

Track Institutional and Insider Activities on EXAS

Follow EXACT SCIENCES CORP and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EXAS shares.

Notify only if

Insider Trading

Get notified when an Exact Sciences Corp insider buys or sells EXAS shares.

Notify only if

News

Receive news related to EXACT SCIENCES CORP

Track Activities on EXAS